Company
United StatesPublic company, NASDAQ: AMRXAmneal Pharmaceuticals LLC (NASDAQ: AMRX), East Hanover, NJ – FDA Inspections
Inspection records and compliance data for Amneal Pharmaceuticals LLC in East Hanover, New Jersey. 3 FDA inspections on record, 1 Form 483, last inspected November 28, 2018. Publicly traded as NASDAQ: AMRX.
Company Profile
This profile covers Amneal Pharmaceuticals LLC based in East Hanover, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected May 30, 2013. Last inspected November 28, 2018.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 28, 2018 | VAI | Human Drugs · Drug Quality Assurance | 1073966 |
| February 21, 2017 | NAI | Human Drugs · Drug Quality Assurance | 1001737 |
| May 30, 2013 | NAI | Human Drugs · Drug Quality Assurance | 833538 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Amneal Pharmaceuticals LLC
Stock ticker
AMRX
Exchange
NASDAQ
Share price
$21.70
Market cap
$7.6B
Price as of
November 13, 2026
FEI Number
3009268752
Address
1 Murray Rd, East Hanover, New Jersey 07936, United States
Country
United States
ID: dfe28c99-faab-4039-90dc-5d5c55de1095